SGLT2i could inhibit aberrant glycolysis (163)
A new era for oral peptides: SNAC and the development of oral semaglutide for the treatment of type 2 diabetes. Therapeutic Advances in Endocrinology and Metabolism
Injection-site reactions Mild redness or swelling at the injection site is common, especially during early titration
People who struggle with nausea or vomiting on other treatments may tolerate Cagrilintide better
Company-reported Phase 3 topline results have circulated in 20252026, and a regulatory filing has been anticipated, but retatrutide is not FDA- or EMA-approved and is not available as a prescription product
Thymosin Alpha-1 10mg A 28-amino acid thymus-derived peptide approved in over 35 countries as Zadaxin, with substantial clinical evidence for viral infection treatment, cancer immunotherapy synergy, and vaccine response enhancement